Articles

Aphea.Bio secures €14 million Series B financing to further develop its next generation agricultural biologicals

This funding further strengthens Aphea.Bio’s plans to advance its biostimulant and biofungicide research and development programs towards submission of the regulatory dossier and to support the launch of the company’s first products.